Remove 2024 Remove Clinic Remove Provider Remove Vaccination
article thumbnail

Population learning: vaccination against respiratory infections in the McGill sites of the Cohort in Primary Care (COPRI) [Acute respiratory infections]

Annals of Family Medicine

Vaccines can prevent several respiratory infections, but the uptake is variable. To improve preventive first line healthcare, we need to understand the uptake and perspective of patients on vaccines. Results: 166 participants were recruited from 6 sites as of April 16 2024, with a median age of 56 (IQR 39-70) years, 31.9%

article thumbnail

Many Older People Embrace Vaccines. Research Is Proving Them Right.

Physician's Weekly

Kim Beckham, an insurance agent in Victoria, Texas, had seen friends suffer so badly from shingles that she wanted to receive the first approved shingles vaccine as soon as it became available, even if she had to pay for it out-of-pocket. Some older people are really eager to be vaccinated. Kennedy Jr.,

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Texas invests $50M in psychedelic drug research to treat addiction

Medical Xpress

The goal is to support clinical trials and bring in another $50 million in private investment to help ibogaine win approval from the U.S. A 2024 study published in the journal Nature Medicine found that military veterans with brain injuries saw major mental and physical improvements after just one ibogaine session.

article thumbnail

Rewiring the body clock: Deep brain imaging reveals unexpected complexity in jet lag adjustment

Medical Xpress

DOI: 10.1038/s41467-025-58661-1 Journal information: Nature Communications Provided by National Taiwan University Citation : Rewiring the body clock: Deep brain imaging reveals unexpected complexity in jet lag adjustment (2025, June 16) retrieved 16 June 2025 from [link] This document is subject to copyright.

Provider 109
article thumbnail

CMS Final Medicaid Drug Rebate Rule Details New Misclassification Penalties and Numerous Other Changes

FDA Law

CMS did not finalize the price verification survey, which would have required manufacturers of 10 costly drugs selected annually to provide clinical information as well as information on production, distribution, research, and marketing costs, revenue and profit, and ex-U.S. pricing, among other things.

article thumbnail

Every Claim You Make, Every Step You Take…CVM Will Be Watching You

FDA Law

Elanco is the manufacturer of recently approved Zenrelia (ilunocitinib tablets) (September 2024), which is indicated for control of pruritus associated with allergic dermatitis and control of atopic dermatitis in dogs at least 12 months of age. Further, information presented on the adverse reaction data was inconsistent with the PI.

article thumbnail

A Review of H5N1

Alabama Academy of Family Physicians

cases in 2024-2025, H5N1 disease in humans had a high mortality rate of up to 50%. since 2024, have primarily been very mild with symptoms consisting of conjunctivitis and upper respiratory symptoms with or without fever. Also, CDC has provided a candidate vaccine virus to manufacturers for rapid production if needed.